Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TRUPCR Europe is a private UK molecular diagnostics company that develops, manufactures, and supplies qPCR and NGS in vitro diagnostic products. The company focuses on commercial assay kits for oncology, infectious diseases, human genetics, pharmacogenetics, and antimicrobial resistance, with products designed for use across multiple real-time PCR platforms. Its portfolio includes CE-IVD and research-use assays such as respiratory pathogen panels, meningitis panels, leukemia panels, BCR-ABL kits, and mutation/fusion detection tests for targets including JAK2, CALR, IDH1/2, ALK, and ROS1. TRUPCR Europe positions itself as an all-in-one kit supplier with internationally aligned assay design, software-enabled analysis for selected products, and technical support for laboratory customers. The business appears to operate primarily as a commercial diagnostics supplier rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TRUPCR.